HopeStage
Back to all studies
CompletedNCT00159965

Sertraline for depression and anxiety in people with nonepileptic seizures

About this titleRead the official source — NCT00159965
Medication studyAges 18–95United StatesPTSD
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 95 years.

Listed locations
ProvidenceSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2003
Recruitment status
Completed
Enrollment listed in the registry
38
Sponsor
Rhode Island Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 95 Years
Official registry ID
NCT00159965
Official title
Show the full official title

Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Providence

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rhode Island Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including sertraline and placebo.

Who was this study for?

Listed age limits: 18 years to 95 years.

Want to explore more studies?

Explore studies